Marshall Wace LLP decreased its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 85.3% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,526 shares of the healthcare conglomerate’s stock after selling 84,090 shares during the period. Marshall Wace LLP’s holdings in UnitedHealth Group were worth $3,564,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also recently bought and sold shares of UNH. Ballentine Partners LLC grew its holdings in shares of UnitedHealth Group by 2.3% in the second quarter. Ballentine Partners LLC now owns 9,038 shares of the healthcare conglomerate’s stock worth $2,218,000 after purchasing an additional 202 shares during the last quarter. Nikulski Financial Inc. lifted its stake in UnitedHealth Group by 1.8% in the second quarter. Nikulski Financial Inc. now owns 11,759 shares of the healthcare conglomerate’s stock worth $2,885,000 after acquiring an additional 205 shares during the period. Trustcore Financial Services LLC lifted its stake in UnitedHealth Group by 34.1% in the second quarter. Trustcore Financial Services LLC now owns 810 shares of the healthcare conglomerate’s stock worth $199,000 after acquiring an additional 206 shares during the period. Lara May & Associates LLC lifted its stake in UnitedHealth Group by 22.2% in the first quarter. Lara May & Associates LLC now owns 1,146 shares of the healthcare conglomerate’s stock worth $246,000 after acquiring an additional 208 shares during the period. Finally, Liberty Capital Management Inc. lifted its stake in UnitedHealth Group by 1.3% in the second quarter. Liberty Capital Management Inc. now owns 15,739 shares of the healthcare conglomerate’s stock worth $3,861,000 after acquiring an additional 209 shares during the period. Institutional investors and hedge funds own 85.30% of the company’s stock.
A number of analysts recently weighed in on UNH shares. SunTrust Banks started coverage on shares of UnitedHealth Group in a research note on Monday, June 11th. They issued a “buy” rating and a $300.00 price objective for the company. Raymond James upped their price objective on shares of UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a research note on Monday. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, May 31st. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday, July 18th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $300.00 price objective on shares of UnitedHealth Group in a research note on Thursday, July 5th. Two analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $275.87.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.04 by $0.10. The business had revenue of $56.09 billion during the quarter, compared to analyst estimates of $56.10 billion. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The company’s quarterly revenue was up 12.1% on a year-over-year basis. During the same period in the prior year, the firm posted $2.46 earnings per share. analysts predict that UnitedHealth Group Inc will post 12.72 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 18th. Shareholders of record on Friday, September 7th were given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 1.37%. The ex-dividend date was Thursday, September 6th. UnitedHealth Group’s payout ratio is 35.75%.
UnitedHealth Group declared that its Board of Directors has approved a stock buyback plan on Wednesday, June 6th that authorizes the company to repurchase 100,000,000 shares. This repurchase authorization authorizes the healthcare conglomerate to repurchase shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.
In related news, Director Kenneth Irwin Shine sold 177 shares of the stock in a transaction that occurred on Wednesday, July 18th. The shares were sold at an average price of $255.72, for a total value of $45,262.44. Following the completion of the transaction, the director now directly owns 29,053 shares of the company’s stock, valued at approximately $7,429,433.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 10,000 shares of the stock in a transaction that occurred on Wednesday, August 8th. The shares were sold at an average price of $258.83, for a total transaction of $2,588,300.00. Following the completion of the transaction, the director now directly owns 77,172 shares of the company’s stock, valued at $19,974,428.76. The disclosure for this sale can be found here. Over the last three months, insiders have sold 94,745 shares of company stock valued at $24,995,290. Insiders own 0.87% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Should You Consider an Index Fund?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.